Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™)...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced...

Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the 22nd Annual Needham Growth Conference at the Lotte New York Palace hotel. Lindon Robertson,...

Sense Photonics, a breakout LiDAR company known for its revolutionary solid-state FLASH architecture, has officially entered the automotive market with the introduction of Osprey, the first...

ZyVersa Therapeutics, Inc. (ZyVersa), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of renal and inflammatory diseases, is pleased to announce that